Should lder In Injury ry Related to Vaccine Admin inistration (S - - PowerPoint PPT Presentation

should lder in injury ry related to vaccine
SMART_READER_LITE
LIVE PREVIEW

Should lder In Injury ry Related to Vaccine Admin inistration (S - - PowerPoint PPT Presentation

Should lder In Injury ry Related to Vaccine Admin inistration (S (SIRVA) Georgie Lewis Clinical Manager SAEFVIC CVU Monash 25.11.2019 @ Murdoch Childrens Research Institute, 2017 SIRVA what you wil ill get out of f th this


slide-1
SLIDE 1

@ Murdoch Children’s Research Institute, 2017

Should lder In Injury ry Related to Vaccine Admin inistration (S (SIRVA)

Georgie Lewis Clinical Manager – SAEFVIC

CVU Monash 25.11.2019

slide-2
SLIDE 2

2

SIRVA – what you wil ill get out of f th this session

  • SIRVA – what is it?
  • Overview of cases reported to SAEFVIC
  • Impact/implications
  • How to avoid it
  • Future
slide-3
SLIDE 3

3

SIRVA – what is is it it?

  • Suspected inadvertent delivery of vaccine into the shoulder joint +/-

surrounding structures

  • Associated diagnosis of bursitis on clinical assessment or medical

imaging

  • Bursitis likely related to vaccine components – adjuvants/antigens

causing an inflammatory response

  • Structural changes likely due to mechanical trauma from the needle
  • Shoulder injury likely due to poor injection technique/individuals

anatomy

slide-4
SLIDE 4

4

Defi finition of f SIRVA – SAEFVIC coding

  • Rapid onset of shoulder pain - <48 hours
  • Pain on movement
  • Restriction of movement in the affected limb/joint
  • Abnormalities on medical imaging
  • Suspicion of incorrect vaccine administration technique
slide-5
SLIDE 5

Reported cases of f SI SIRVA by year

5 10 15 20 25 30 35 2007 2009 2010 2012 2013 2014 2015 2016 2017 2018 2019

Number of cases Year

Reported cases by year

slide-6
SLIDE 6

6

Clinically confirmed SIRVA on ult ltrasound

Of the 67 reports of SIRVA made to SAEFVIC;

  • 33 of 67 (50%) reported cases had a clinical diagnosis of Bursitis on

ultrasound/radiological imaging

  • 6 of the 33 cases were also diagnosed with impingement syndrome
  • 3 of the 33 cases were also diagnosed with tendonitis
  • 2 of the 33 cases were also diagnosed with supraspinatus tear
slide-7
SLIDE 7

7

Symptoms of f SIRVA +/- dia iagnosis of f bursitis on im imaging

Cases reported some or all of the following symptoms;

  • Rapid onset of pain in shoulder of immunised arm
  • Pain with certain movements – abduction/adduction
  • Restricted movement of shoulder
  • Unable to carry out activities of daily living ie; hanging out washing , driving,

dressing

slide-8
SLIDE 8

Ti Timing of f symptom onset aft fter vaccine administration

Sales

1st Qtr 2nd Qtr 3rd Qtr 4th Qtr

Onset of symptoms Cases Immediate 29 >immediate ≤24 hours 28 >24 hours ≤48 hours 6 >48 hours Although 2 cases reported onset of symptoms >48 hours they still fit within clinical definition

  • f SIRVA

2 Unknown 2

slide-9
SLIDE 9

SI SIRVA cases by vaccine ty type

Vaccine type Cases Influenza 41 dTpa 17 Pneumovax 5 Meningococcal B 4 Human Papilloma Virus 3 Meningococcal ACWY 1

*note some cases received more than 1 vaccine at the visit eg; Influenza +/- dTpa/Pneumovax

59% 24% 7% 6% 4%

SIRVA by vaccine type

Influenza dTpa Pneumovax Meningococcal B HPV

slide-10
SLIDE 10

SIRVA cases by provider

Provider type Cases % GP 24 36% Hospital – nurse/staff health/doctor 18 27% Council Nurse 10 15% Practice nurse 6 9% Pharmacist 5 7% Other/unknown 4 6% Total 67 100%

36% 27% 15% 9% 7% 6% GP Hospital Council Nurse Practice Nurse Pharmacist Other/Unknown

slide-11
SLIDE 11

SI SIRVA versus overall AEFI reports by provider ty type

0% 5% 10% 15% 20% 25% 30% 35% 40% 45% 50% Unknown Community Clinic Council GP Hospital Interstate/Overseas Other Pharmacy Workplace

Proportion of reports received by vaccine provider type

Reports% SIRVA%

slide-12
SLIDE 12

Management of f SIRVA cases

Specialist

  • GP
  • Emergency department
  • Orthopaedic/sports physician
  • Rheumatologist
  • Physiotherapy/myotherapy

Treatment

  • Over the counter anti-

inflammatories - NSAIDS

  • Prescription pain relief –

Voltaren, Endone, Panadeine forte,

  • U/S guided cortisone injections
  • Hydrodilation of the shoulder
slide-13
SLIDE 13

13

Im Impact of f SIRVA

  • Difficulty performing ADL’s – dressing, cleaning, driving, hanging out

washing , driving, dressing

  • Difficulty sleeping due to pain
  • Time off work/school
  • Unable to participate in sporting activities/championships
  • Compensation
slide-14
SLIDE 14

14

Im Implications of f SIR IRVA

  • Vaccine hesitancy
  • Immunogenicity of vaccine given - ?immunogenic if given into

shoulder joint as opposed to deltoid muscle

  • Consumer confidence in health care providers
  • Cost of treatments
  • Emotional and mental impact on vaccinee and families
slide-15
SLIDE 15

15

Shoulder In Inju jury ry Rela lating to Vaccine Admin inistration (SIR IRVA)

To avoid causing a shoulder injury related to vaccine administration:

  • Ensure you can visualise the deltoid from the shoulder to the elbow
  • Be familiar with the anatomical landmarks and surrounding structures
  • Follow recommended immunisation administration techniques
  • Aim for the middle of the deltoid
  • Do NOT inject too high or too low
  • For appropriate assessment, diagnosis and management report any suspected cases of SIRVA to

SAEFVIC (Vic only) online at www.saefvic.org.au or by phone 1300 882 924 (Option 1).

slide-16
SLIDE 16

Sh Shoulder In Inju jury ry Rela lating to Vaccine Admin inistration (SI SIRVA)

To locate the deltoid site for injection:

  • Expose the arm completely, from the top of the

shoulder to the elbow; remove the shirt/clothing if needed.

  • Locate the shoulder tip (acromion) and the muscle

insertion at the middle of the humerus (deltoid tuberosity).

  • Draw an imaginary inverted triangle below the

shoulder tip, using the identified anatomical markers.

  • The deltoid site for injection is halfway between

the acromion and the deltoid tuberosity, in the middle of the muscle (triangle).

  • More than 1 vaccine may be given into the deltoid

muscle ensuring the deltoid mass is adequate and each vaccine is separated by 2.5cm.

slide-17
SLIDE 17

17

In Inje jection techniq ique

Too high! Too low!

slide-18
SLIDE 18

18

Locatin ing correct anatomical la landmarks

Injection technique: CORRECT!

slide-19
SLIDE 19

What have we done to prevent further cases?

  • Australian Immunisation Handbook - Avoiding shoulder

injury related to vaccine administration

  • https://immunisationhandbook.health.gov.au/resource

s/publications/avoiding-shoulder-injury-related-to- vaccine-administration

slide-20
SLIDE 20

20

Sh Should lder In Inju jury ry Rela latin ing to Vaccin ine Admin inis istratio ion (S (SIR IRVA)

slide-21
SLIDE 21

What have we done to prevent further cases?

Administration of injected vaccines – correct technique

  • https://mvec.mcri.edu.au/immunisation-references/administration-of-

injected-vaccines-correct-technique/ Shoulder Injury Related to Vaccine Administration

  • https://mvec.mcri.edu.au/immunisation-references/shoulder-injury-

related-to-vaccine-administration/

slide-22
SLIDE 22

22

SIR SIRVA where to fr from here?

  • SIRVA is described in literature however no clear definition has been

formulated

  • Publication: SAEFVIC proposing 2 papers;
  • 1 - Descriptive – intro/methods/results/discussion with the aim for the end

point to be case definition (SAEFVIC coding and look to formalise with Brighton Collaboration definition)

  • 2 – Long term follow up – individual cases, legal and clinical issues, vaccine

safety surveillance

slide-23
SLIDE 23

Take home message

Know your site and get it right!